# A nurse is assessing a 28-year-old patient with suspected aplastic anemia. Which assessment finding would be most indicative of this condition? > source: MyMerci (mymerci.kr) > url: https://mymerci.kr/pages/nclex_q.php?qn_id=540799 > language: ko > subject: Adult Health ## 문제 A nurse is assessing a 28-year-old patient with suspected aplastic anemia. Which assessment finding would be most indicative of this condition? ## 보기 1. Pancytopenia with hypocellular bone marrow biopsy results **✔ 정답** 2. Elevated reticulocyte count with splenomegaly 3. Increased blast cells in peripheral blood smear 4. Hemolysis with elevated indirect bilirubin levels **정답: 1** ## 해설 Pancytopenia with hypocellular bone marrow is the hallmark diagnostic finding for aplastic anemia, indicating bone marrow failure. Other options suggest hemolytic anemia, leukemia, or hemolytic disorders, which are not characteristic of aplastic anemia. ## 심화 해설 Correct Answer Explanation The assessment finding most indicative of aplastic anemia is pancytopenia with a hypocellular bone marrow biopsy. Aplastic anemia is fundamentally a bone marrow failure syndrome. The core pathophysiological definition, as highlighted in the provided literature, is a marked decrease in the production of all blood cell lines (pancytopenia) resulting from a bone marrow that is empty or fatty (hypocellular) [1,2,4]. This is not a condition of peripheral destruction or malignant infiltration, but rather a primary failure of the marrow to manufacture adequate cells. To understand this, think of the bone marrow as a factory. In aplastic anemia, the factory's production floor is nearly empty—there are very few worker cells (hematopoietic stem cells) and the space is filled with non-productive fat. This directly leads to a shortage of all products shipped to the peripheral blood: red blood cells, white blood cells, and platelets. The diagnosis is confirmed by a bone marrow biopsy showing this profound hypocellularity in the context of peripheral pancytopenia [1,2,3]. The other options describe mechanisms or findings associated with different hematologic disorders, not the primary failure of production seen in aplastic anemia. Distractor Analysis - Option 2: Elevated reticulocyte count with splenomegaly. This finding is more consistent with a hemolytic anemia. When red blood cells are destroyed prematurely (hemolysis), the bone marrow factory is intact and tries to compensate by dramatically increasing production of young red blood cells, known as reticulocytes. The spleen, a primary site of red blood cell destruction, often enlarges (splenomegaly) as it works overtime. In aplastic anemia, the factory has failed, so the reticulocyte count would be low, not high. - Option 3: Increased blast cells in peripheral blood smear. The presence of immature, non-functional blast cells in the peripheral blood is a hallmark of acute leukemia. In leukemia, the bone marrow is packed with malignant cells that may spill into the bloodstream. This is a state of a hypercellular, not hypocellular, marrow. Aplastic anemia is defined by a lack of all cells, including blasts. - Option 4: Hemolysis with elevated indirect bilirubin levels. This combination points toward a hemolytic process, such as in an autoimmune hemolytic anemia or a hemoglobinopathy like sickle cell disease. The elevated indirect (unconjugated) bilirubin is a byproduct of excessive hemoglobin breakdown from destroyed red blood cells. The primary problem in aplastic anemia is underproduction, not over-destruction, of cells. Pathophysiology Deep Dive The pathogenesis of acquired aplastic anemia is often immune-mediated, where autoreactive T-cells attack and destroy hematopoietic stem and progenitor cells. However, recent research, such as the study by Saxena et al., points to an additional, critical layer of dysfunction within the bone marrow microenvironment itself [1]. The mesenchymal stem cells (BM-MSCs) that form the supportive "soil" for the hematopoietic "seeds" are intrinsically abnormal. These defective BM-MSCs show a tendency to differentiate into adipocytes (fat cells) rather than bone-forming cells, contributing directly to the fatty, hypocellular marrow observed on biopsy. They also exhibit cellular senescence and a chronic inflammatory state, failing to provide the necessary support for blood cell production [1]. This dual hit—immune destruction of stem cells and a failing supportive niche—explains the profound and persistent pancytopenia. Clinical Application & Assessment When assessing a patient with suspected aplastic anemia, your clinical findings will be a direct reflection of the pancytopenia. A low platelet count (thrombocytopenia) manifests as petechiae, purpura, and spontaneous gum bleeding, as described in the case of the 3-year-old child with an inherited form of the disease [4]. Anemia leads to fatigue, pallor, and dyspnea. The most life-threatening immediate risk stems from severe neutropenia, which leaves the patient vulnerable to overwhelming infections and neutropenic sepsis. A case report on a 4-year-old with severe aplastic anemia illustrates how rapidly a patient can deteriorate during a febrile neutropenic episode, requiring critical interventions like ECMO support [3]. Your assessment must prioritize monitoring for signs of infection (fever is often the only sign), bleeding, and symptoms of severe anemia. The definitive diagnostic finding, however, remains the combination of peripheral pancytopenia and a bone marrow biopsy revealing a markedly hypocellular marrow with fatty replacement [1,2]. References (research sources) - [1]Epigenomic dysregulation in the bone marrow mesenchymal stem cells of acquired aplastic anemia patients: An in silico and in vitro study.Research articleSaxena P, Upadhyaya A, Rai B, Srivastava J, Gupta R, Yadav S, Chaturvedi CP. (2026) · DOI: 10.1007/s11033-026-12337-1 - [3]Extracorporeal Membrane Oxygenation in Pediatric Severe Aplastic Anemia: A Case Report Highlighting Risk-Benefit and Ethical Considerations.Case reportAbraham AS, Mathew MM, Thomas L, Abraham J, Butala M. (2026) · DOI: 10.7759/cureus.105764 - [4]Inherited bone marrow failure with ERCC6L2 gene mutation: presentation of aplastic anemia in a 3-year-old child: a case report.Case reportMengistu AG, Heyi YS, Temesgen NE, Aweke SK, Assale NM, Tsega HM, Merahi MK. (2026) · DOI: 10.1186/s13256-026-06265-8 ## 임상 시나리오 Aplastic Anemia: Key Diagnostic FindingConfirming Bone Marrow Failure The hallmark of aplastic anemia is pancytopenia confirmed by a hypocellular bone marrow biopsy. The marrow is replaced by fat, failing to produce adequate red cells, white cells, and platelets. A reticulocyte count is typically low, reflecting a lack of red blood cell production. This distinguishes it from hemolytic anemias where reticulocytes are elevated. CautionDo not confuse with leukemia, which shows increased blast cells on a peripheral smear, or hemolytic anemia, which presents with splenomegaly and elevated indirect bilirubin. ## 핵심 개념 - **Pancytopenia** — A reduction in all three major blood cell lines: red blood cells (anemia), white blood cells (leukopenia), and platelets (thrombocytopenia). - **Hypocellular Bone Marrow** — A bone marrow biopsy finding showing a marked decrease in hematopoietic stem cells, replaced by fat, indicating marrow failure. - **Aplastic Anemia** — A bone marrow failure syndrome characterized by pancytopenia and a hypocellular marrow without malignant infiltration or fibrosis. - **Reticulocyte Count** — A measure of young red blood cells; typically low in aplastic anemia due to lack of production, but elevated in hemolytic anemia. - **Bone Marrow Biopsy** — The definitive diagnostic test for aplastic anemia, revealing the cellularity and architecture of the marrow. ## 같은 주제 문제 - [A nurse is assessing a 28-year-old patient with suspected aplastic anemia. Which assessmen…](https://mymerci.kr/pages/nclex_q.php?qn_id=540798) - [A nurse is caring for a patient with aplastic anemia. Which assessment finding would be th…](https://mymerci.kr/pages/nclex_q.php?qn_id=540800) - [A nurse is caring for a patient with aplastic anemia who has a platelet count of 15,000/mm…](https://mymerci.kr/pages/nclex_q.php?qn_id=540801) - [A nurse is caring for a patient with aplastic anemia who has developed severe thrombocytop…](https://mymerci.kr/pages/nclex_q.php?qn_id=540802) - [A nurse is caring for a client with severe aplastic anemia who has a platelet count of 5,0…](https://mymerci.kr/pages/nclex_q.php?qn_id=540803) - [A nurse is caring for a 45-year-old patient with aplastic anemia who has a platelet count …](https://mymerci.kr/pages/nclex_q.php?qn_id=540804) - [A nurse is caring for a patient with acute myeloid leukemia who has a platelet count of 15…](https://mymerci.kr/pages/nclex_q.php?qn_id=540805) --- More free questions: [기출문제](https://mymerci.kr/) _학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._